Re "only about factual accuracy. Ahem"
Show me one of my factual errors, remember less accusation .. more proof. I don't mean the ones you disagree with, but those that are definitely wrong.
I would guess I could find, conservatively, at least 20 posts of yours complete with pure invention. From magic catheters to non diluting equity facilities, you're a mine of misinformation.
Now quit, before I get you back to explaining why you said Teva's unilateral termination was only possible if efficacy was not being met, or why the Chf market in Japan was about to take off 18 months ago, or even how all those smart analysts in the US would get MSB in a way no Australian ever would.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment
MSB
mesoblast limited
Add to My Watchlist
3.88%
!
$2.23
Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-77
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
